These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8567329)

  • 1. Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation?
    Krol AD; Aussems P; Noordijk EM; Hermans J; Leer JW
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):297-302. PubMed ID: 8567329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer.
    Hayakawa K; Mitsuhashi N; Saito Y; Nakayama Y; Furuta M; Sakurai H; Kawashima M; Ohno T; Nasu S; Niibe H
    Lung Cancer; 1999 Dec; 26(3):137-42. PubMed ID: 10598923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elective nodal failures are uncommon in medically inoperable patients with Stage I non-small-cell lung carcinoma treated with limited radiotherapy fields.
    Bradley JD; Wahab S; Lockett MA; Perez CA; Purdy JA
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):342-7. PubMed ID: 12738307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: a retrospective multivariate analysis.
    Hazuka MB; Turrisi AT; Lutz ST; Martel MK; Ten Haken RK; Strawderman M; Borema PL; Lichter AS
    Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):273-84. PubMed ID: 8407401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.
    Sibley GS; Jamieson TA; Marks LB; Anscher MS; Prosnitz LR
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):149-54. PubMed ID: 9422571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy.
    Rosenzweig KE; Sim SE; Mychalczak B; Braban LE; Schindelheim R; Leibel SA
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):681-5. PubMed ID: 11395236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: is low incidence of regional failure due to incidental nodal irradiation?
    Chen M; Hayman JA; Ten Haken RK; Tatro D; Fernando S; Kong FM
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):120-6. PubMed ID: 16198503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial.
    De Ruysscher D; Bremer RH; Koppe F; Wanders S; van Haren E; Hochstenbag M; Geeraedts W; Pitz C; Simons J; ten Velde G; Dohmen J; Snoep G; Boersma L; Verschueren T; van Baardwijk A; Dehing C; Pijls M; Minken A; Lambin P
    Radiother Oncol; 2006 Sep; 80(3):307-12. PubMed ID: 16949169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation therapy alone for stage I non-small cell lung cancer.
    Kaskowitz L; Graham MV; Emami B; Halverson KJ; Rush C
    Int J Radiat Oncol Biol Phys; 1993 Oct; 27(3):517-23. PubMed ID: 8226143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy.
    Senan S; Burgers S; Samson MJ; van Klaveren RJ; Oei SS; van Sörnsen de Koste J; Voet PW; Lagerwaard FJ; Maarten van Haarst J; Aerts JG; van Meerbeeck JP
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(4):999-1006. PubMed ID: 12419425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas.
    Fukumoto S; Shirato H; Shimzu S; Ogura S; Onimaru R; Kitamura K; Yamazaki K; Miyasaka K; Nishimura M; Dosaka-Akita H
    Cancer; 2002 Oct; 95(7):1546-53. PubMed ID: 12237924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between elective nodal failure and irradiated volume in non-small-cell lung cancer (NSCLC) treated with radiotherapy using conventional fields and doses.
    Sanuki-Fujimoto N; Sumi M; Ito Y; Imai A; Kagami Y; Sekine I; Kunitoh H; Ohe Y; Tamura T; Ikeda H
    Radiother Oncol; 2009 Jun; 91(3):433-7. PubMed ID: 19167118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformal high dose external radiation therapy, 80.5 Gy, alone for medically inoperable non-small cell lung cancer: a retrospective analysis.
    Urbanic JJ; Turrisi AT; Sharma AK; Silvestri GA; Williams TE; Vanek KN; Sherman CA
    J Thorac Oncol; 2006 Feb; 1(2):112-9. PubMed ID: 17409839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy for medically inoperable non-small cell lung cancer at clinical stage I and II.
    Yamada K; Soejima T; Ota Y; Sasaki R; Yoden E; Kanaoka N; Maruta T; Sugimura K
    Tumori; 2003; 89(1):75-9. PubMed ID: 12729366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.
    Komaki R; Scott CB; Sause WT; Johnson DH; Taylor SG; Lee JS; Emami B; Byhardt RW; Curran WJ; Dar AR; Cox JD
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):537-44. PubMed ID: 9336129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment the efficacy of postoperative radiotherapy in the patients with non-small cell lung cancer. Retrospective study].
    Chmielewska E; Jodkiewicz Z; Karwański M
    Pneumonol Alergol Pol; 2012; 80(2):109-19. PubMed ID: 22370979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial.
    Rosenman JG; Halle JS; Socinski MA; Deschesne K; Moore DT; Johnson H; Fraser R; Morris DE
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):348-56. PubMed ID: 12243807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose, hyperfractionated, accelerated radiotherapy using a concurrent boost for the treatment of nonsmall cell lung cancer: unusual toxicity and promising early results.
    King SC; Acker JC; Kussin PS; Marks LB; Weeks KJ; Leopold KA
    Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):593-9. PubMed ID: 8948343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy alone.
    Kupelian PA; Komaki R; Allen P
    Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):607-13. PubMed ID: 8948345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy for patients with medically inoperable Stage I nonsmall cell lung carcinoma: smaller volumes and higher doses--a review.
    Sibley GS
    Cancer; 1998 Feb; 82(3):433-8. PubMed ID: 9452258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.